BMD improvements after operation for primary hyperparathyroidism (Q44217990)

30 November 2017

title

BMD improvements after operation for primary hyperparathyroidism (English)

1 reference

30 November 2017

1 reference

1 reference

30 November 2017

1 reference

30 November 2017

Leif Mosekilde

1 reference

30 November 2017

Lars Rolighed

1 reference

30 November 2017

Peter Vestergaard

series ordinal

1 reference

30 November 2017

Lene Heickendorff

series ordinal

1 reference

30 November 2017

Peer Christiansen

series ordinal

1 reference

30 November 2017

language of work or name

English

0 references

publication date

7 November 2012

1 reference

Langenbeck's Archives of Surgery

30 November 2017

published in

1 reference

30 November 2017

volume

398

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

113-120

1 reference

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Arterial stiffness in mild primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Primary hyperparathyroidism and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Current pharmacological options for the management of primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Vitamin D treatment in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

The effects of vitamin D insufficiency in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Medical Treatment of Primary, Secondary, and Tertiary Hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Effect of renal function on skeletal health in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Effects of smoking on severity of disease in primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Diagnosis and management of primary hyperparathyroidism in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1026-5

Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention

21 January 2018

1 reference

12 December 2020

Differential diagnosis of hypercalcemia

1 reference

12 December 2020

The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.

1 reference

12 December 2020

Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests

1 reference

12 December 2020

NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement

1 reference

12 December 2020

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century

1 reference

12 December 2020

Primary hyperparathyroidism and the risk of fracture: a population-based study

1 reference

12 December 2020

10.1007/S00423-012-1026-5

Identifiers

DOI

1 reference

30 November 2017

1 reference